However, recent efforts have focused on developing alternative methods to examine AD neuropathology with the goal to identify initial AD signs antemortem, as for example, using positron-emission tomography (PET) scans for tau and Aβ imaging as discussed below, to indicate that the presence of sufficient quantities of both would permit a diagnosis of AD. The gene discussed is MAPT; the disease is Alzheimer disease.